Searched for
ESCITALOPRAM
Over 200 drugs under development, top 50 with $30 billion potential: CiplaElaborating on the pipeline for new drugs, Cipla said it has over 200 drugs under development with the top 50 projects having potential of ...13 Jan, 2016, 04.08 PM IST- Cipla set to buy American business of Hetero Drugs for $550 millionPeople close to the transaction said Cipla will buy Invagen and Camber, Hetero’s wholly owned subsidiary, for about $550 million.04 Sep, 2015, 04.33 PM IST
- Hetero buy will boost Cipla's US ops in next 2-3 years; hold stock @ target of Rs 755: Praful Bohra, Religare"Cipla's portfolio is of a commodity generics type; so this will definitely place it in a strong position in terms of product pipeline in t...04 Sep, 2015, 11.19 AM IST
- Single dose of antidepressant changes brainA single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain, scientists have fo...20 Sep, 2014, 12.13 PM IST
- Jubilant Life's four medicines get USFDA approvalJubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.20 Sep, 2012, 06.32 PM IST
- Ten stocks in focus in Friday morning tradeIndian shares are expected to trade higher. Here is a list of ten stocks that are likely to be in action in morning trade today.14 Sep, 2012, 08.11 AM IST
- Aurobindo Pharma gets USFDA approval for anti-depressantAurobindo Pharma said it has received final approval from the US health regulator to manufacture generic version of Lexapro.12 Sep, 2012, 03.50 PM IST
- Cipla to meet revised targetsFor Cipla which has seen a recovery in growth in the past two quarters, the performance in the quarter to June was one of its best.01 Aug, 2012, 05.04 AM IST
- Surya Pharma launches neuropsychiatric divisionThe Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN .01 Nov, 2011, 10.48 PM IST
- Sun's Caraco settles litigation with Forest Lab in USThe Rs 4,300-crore Sun Pharmaceuticals Ltd's US-subsidiary, Caraco Pharmaceuticals Laboratories Ltd, has gone for settlement of the legal p...10 Jul, 2009, 09.56 PM IST
- Sun Pharma enters pact with Forest Labs,H Lundbeck for LexaproSun Pharma and its US subsidiary Caraco Pharma have entered into agreements with Forest Laboratoriesa and H Lundbeck to settle legal procee...10 Jul, 2009, 09.20 PM IST
- Aurobindo settled 3% up on bourses after deal with PfizerAurobindo Pharma on Wednesday surged three per cent on bourses, a day after the Indian drug maker entered into multiple agreements with US-...04 Mar, 2009, 06.44 PM IST
- Aurobindo gets USFDA nod for anti-depressantDrug major Aurobindo Pharma on Wednesday said it has got tentative USFDA approval to market escitalopram oxalate tablets.04 Mar, 2009, 02.30 PM IST
- Aurobindo gets USFDA approval for two generic drugsAurobindo Pharma Ltd has received tentative approval form US Food Drug Administration for perindopril erbumine tablets 2mg, 4mg, 8mg and es...05 Dec, 2008, 12.03 PM IST
- Cadila gets FDA approval to market four drugs in USPharma major Zydus Cadila on Thursday said it has received approval from the US FDA to market four products, including anti-depressant Esci...15 May, 2008, 02.33 PM IST
Load More
